<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="jco"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC2793040/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793040/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Journal of Clinical Oncology"><meta name="citation_title" content="Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects"><meta name="citation_authors" content="Lisa R. Treviño, Noriko Shimasaki, Wenjian Yang, John C. Panetta, Cheng Cheng, Deqing Pei, Diana Chan, Alex Sparreboom, Kathleen M. Giacomini, Ching-Hon Pui, William E. Evans, Mary V. Relling"><meta name="citation_date" content="10 December 2009"><meta name="citation_issue" content="35"><meta name="citation_volume" content="27"><meta name="citation_firstpage" content="5972"><meta name="citation_doi" content="10.1200/JCO.2008.20.4156"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2793040/?report=abstract"><meta name="citation_pmid" content="19901119"><meta name="DC.Title" content="Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="American Society of Clinical Oncology"><meta name="DC.Contributor" content="Lisa R. Treviño"><meta name="DC.Contributor" content="Noriko Shimasaki"><meta name="DC.Contributor" content="Wenjian Yang"><meta name="DC.Contributor" content="John C. Panetta"><meta name="DC.Contributor" content="Cheng Cheng"><meta name="DC.Contributor" content="Deqing Pei"><meta name="DC.Contributor" content="Diana Chan"><meta name="DC.Contributor" content="Alex Sparreboom"><meta name="DC.Contributor" content="Kathleen M. Giacomini"><meta name="DC.Contributor" content="Ching-Hon Pui"><meta name="DC.Contributor" content="William E. Evans"><meta name="DC.Contributor" content="Mary V. Relling"><meta name="DC.Date" content="2009 Dec 10"><meta name="DC.Identifier" content="10.1200/JCO.2008.20.4156"><meta name="DC.Language" content="en"><meta property="og:title" content="Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects"><meta property="og:type" content="article"><meta property="og:description" content="Methotrexate plasma concentration is related to its clinical effects. Our aim was to identify the genetic basis of interindividual variability in methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia (ALL).We performed ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793040/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-jco.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2793040/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2793040/pdf/zlj5972.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8DC649DD5046010000000000BA0070.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2793040%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=%22J Clin Oncol%22[journal]" class="navlink">J Clin Oncol</a></li><li class="accid">PMC2793040</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-jco.gif" alt="Logo of jco" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,56,105,76" alt="Home" title="Home" href="http://jco.ascopubs.org" ref="reftype=publisher&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="104,56,258,76" alt="This Article" title="This Article" href="http://jco.ascopubs.org/cgi/content/full/27/35/5972" ref="reftype=publisher&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7CArticle%7CFullText" target="pmc_ext"><area shape="rect" coords="0,0,157,57" href="http://jco.ascopubs.org/" ref="reftype=publisher&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="257,56,380,76" alt="Search" title="Search" href="http://jco.ascopubs.org/search.dtl" ref="reftype=publisher&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="379,56,500,77" alt="Submit" title="Submit" href="http://submit.jco.org/" ref="reftype=publisher&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="poly" coords="450,2,431,9,425,27,429,43,437,54,459,55,471,52,483,42,486,29,479,11,466,2,449,2" alt="ASCO JCO Homepage" title="ASCO JCO Homepage" href="http://jco.ascopubs.org" ref="reftype=publisher&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">J Clin Oncol</a></span>. 2009 Dec 10; 27(35): 5972–5978. </span></div><div><span class="fm-vol-iss-date">Published online 2009 Nov 9. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1200%2FJCO.2008.20.4156" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1200/JCO.2008.20.4156</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2793040</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/19901119">19901119</a></div></div></div></div><h1 class="content-title">Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Trevi%26%23x000f1%3Bo%20LR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119" class="affpopup" co-rid="_co_idm140305972225824" co-class="co-affbox">Lisa R. Treviño</a>,<sup></sup> <a href="/pubmed/?term=Shimasaki%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119" class="affpopup" co-rid="_co_idm140305976024256" co-class="co-affbox">Noriko Shimasaki</a>,<sup></sup> <a href="/pubmed/?term=Yang%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119" class="affpopup" co-rid="_co_idm140305972222992" co-class="co-affbox">Wenjian Yang</a>,<sup></sup> <a href="/pubmed/?term=Panetta%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119" class="affpopup" co-rid="_co_idm140305976077184" co-class="co-affbox">John C. Panetta</a>,<sup></sup> <a href="/pubmed/?term=Cheng%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119" class="affpopup" co-rid="_co_idm140305976075088" co-class="co-affbox">Cheng Cheng</a>,<sup></sup> <a href="/pubmed/?term=Pei%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119" class="affpopup" co-rid="_co_idm140305976072992" co-class="co-affbox">Deqing Pei</a>,<sup></sup> <a href="/pubmed/?term=Chan%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119" class="affpopup" co-rid="_co_idm140305978622912" co-class="co-affbox">Diana Chan</a>,<sup></sup> <a href="/pubmed/?term=Sparreboom%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119" class="affpopup" co-rid="_co_idm140305978620816" co-class="co-affbox">Alex Sparreboom</a>,<sup></sup> <a href="/pubmed/?term=Giacomini%20KM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119" class="affpopup" co-rid="_co_idm140305978618720" co-class="co-affbox">Kathleen M. Giacomini</a>,<sup></sup> <a href="/pubmed/?term=Pui%20CH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119" class="affpopup" co-rid="_co_idm140305976433680" co-class="co-affbox">Ching-Hon Pui</a>,<sup></sup> <a href="/pubmed/?term=Evans%20WE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119" class="affpopup" co-rid="_co_idm140305976431584" co-class="co-affbox">William E. Evans</a>,<sup></sup> and  <a href="/pubmed/?term=Relling%20MV%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119" class="affpopup" co-rid="_co_idm140305976429488" co-class="co-affbox">Mary V. Relling</a><sup></sup><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140305972225824"><h3 class="no_margin">Lisa R. Treviño</h3><p>From St Jude Children's Research Hospital; University of Tennessee Health Science Center, Memphis, TN; University of California, San Francisco, CA.</p><div>Find articles by <a href="/pubmed/?term=Trevi%26%23x000f1%3Bo%20LR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119">Lisa R. Treviño</a></div></div><div id="_co_idm140305976024256"><h3 class="no_margin">Noriko Shimasaki</h3><p>From St Jude Children's Research Hospital; University of Tennessee Health Science Center, Memphis, TN; University of California, San Francisco, CA.</p><div>Find articles by <a href="/pubmed/?term=Shimasaki%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119">Noriko Shimasaki</a></div></div><div id="_co_idm140305972222992"><h3 class="no_margin">Wenjian Yang</h3><p>From St Jude Children's Research Hospital; University of Tennessee Health Science Center, Memphis, TN; University of California, San Francisco, CA.</p><div>Find articles by <a href="/pubmed/?term=Yang%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119">Wenjian Yang</a></div></div><div id="_co_idm140305976077184"><h3 class="no_margin">John C. Panetta</h3><p>From St Jude Children's Research Hospital; University of Tennessee Health Science Center, Memphis, TN; University of California, San Francisco, CA.</p><div>Find articles by <a href="/pubmed/?term=Panetta%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119">John C. Panetta</a></div></div><div id="_co_idm140305976075088"><h3 class="no_margin">Cheng Cheng</h3><p>From St Jude Children's Research Hospital; University of Tennessee Health Science Center, Memphis, TN; University of California, San Francisco, CA.</p><div>Find articles by <a href="/pubmed/?term=Cheng%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119">Cheng Cheng</a></div></div><div id="_co_idm140305976072992"><h3 class="no_margin">Deqing Pei</h3><p>From St Jude Children's Research Hospital; University of Tennessee Health Science Center, Memphis, TN; University of California, San Francisco, CA.</p><div>Find articles by <a href="/pubmed/?term=Pei%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119">Deqing Pei</a></div></div><div id="_co_idm140305978622912"><h3 class="no_margin">Diana Chan</h3><p>From St Jude Children's Research Hospital; University of Tennessee Health Science Center, Memphis, TN; University of California, San Francisco, CA.</p><div>Find articles by <a href="/pubmed/?term=Chan%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119">Diana Chan</a></div></div><div id="_co_idm140305978620816"><h3 class="no_margin">Alex Sparreboom</h3><p>From St Jude Children's Research Hospital; University of Tennessee Health Science Center, Memphis, TN; University of California, San Francisco, CA.</p><div>Find articles by <a href="/pubmed/?term=Sparreboom%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119">Alex Sparreboom</a></div></div><div id="_co_idm140305978618720"><h3 class="no_margin">Kathleen M. Giacomini</h3><p>From St Jude Children's Research Hospital; University of Tennessee Health Science Center, Memphis, TN; University of California, San Francisco, CA.</p><div>Find articles by <a href="/pubmed/?term=Giacomini%20KM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119">Kathleen M. Giacomini</a></div></div><div id="_co_idm140305976433680"><h3 class="no_margin">Ching-Hon Pui</h3><p>From St Jude Children's Research Hospital; University of Tennessee Health Science Center, Memphis, TN; University of California, San Francisco, CA.</p><div>Find articles by <a href="/pubmed/?term=Pui%20CH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119">Ching-Hon Pui</a></div></div><div id="_co_idm140305976431584"><h3 class="no_margin">William E. Evans</h3><p>From St Jude Children's Research Hospital; University of Tennessee Health Science Center, Memphis, TN; University of California, San Francisco, CA.</p><div>Find articles by <a href="/pubmed/?term=Evans%20WE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119">William E. Evans</a></div></div><div id="_co_idm140305976429488"><h3 class="no_margin">Mary V. Relling</h3><p>From St Jude Children's Research Hospital; University of Tennessee Health Science Center, Memphis, TN; University of California, San Francisco, CA.</p><div>Find articles by <a href="/pubmed/?term=Relling%20MV%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19901119">Mary V. Relling</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140306015698944_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140306015698944_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140306015698944_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140306015698944_ai" style="display:none"><div class="fm-affl" id="aff1" lang="en">From St Jude Children's Research Hospital; University of Tennessee Health Science Center, Memphis, TN; University of California, San Francisco, CA.</div><div id="cor1">Corresponding author: Mary V. Relling, PharmD, St Jude Children's Research Hospital, 332 N Lauderdale, Memphis, TN 38105-2794; e-mail: <a href="mailto:dev@null" data-email="gro.edujts@gniller.yram" class="oemail">gro.edujts@gniller.yram</a>.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140306015698944_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2008 Oct 3; Accepted 2009 May 13.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140306015698944_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> © 2009 by American Society of Clinical Oncology</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2793040/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">
               [Data Supplement]
            </div>
            
            <div><a href="/pmc/articles/PMC2793040/bin/JCO.2008.20.4156_index.html" data-ga-action="click_feat_suppl">JCO.2008.20.4156_index.html</a><span style="color:gray"> (870 bytes)</span></div><div class="small guid">GUID:&nbsp;73AF5939-7E0D-4C65-A1AF-2B50907C4EE4</div>
            <div><a href="/pmc/articles/PMC2793040/bin/JCO.2008.20.4156_1.pdf" data-ga-action="click_feat_suppl">JCO.2008.20.4156_1.pdf</a><span style="color:gray"> (629K)</span></div><div class="small guid">GUID:&nbsp;AA85F2C6-BF4F-4C61-B601-68F71CB9F42C</div>
         </div></dd></dl></div><div id="idm140305972509008" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140305972509008title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Purpose</h3><p id="__p1" class="p p-first-last">Methotrexate plasma concentration is related to its clinical effects. Our aim was to identify the genetic basis of interindividual variability in methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia (ALL).</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Patients and Methods</h3><p id="__p2" class="p p-first-last">We performed a genome-wide analysis of 500,568 germline single-nucleotide polymorphisms (SNPs) to identify how inheritance affects methotrexate plasma disposition among 434 children with ALL who received 3,014 courses of methotrexate at 2 to 5 g/m<sup>2</sup>. SNPs were validated in an independent cohort of 206 patients.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p3" class="p p-first-last">Adjusting for age, race, sex, and methotrexate regimen, the most significant associations were with SNPs in the organic anion transporter polypeptide, <em>SLCO1B1.</em> Two SNPs in <em>SLCO1B1</em>, rs11045879 (<em>P</em> = 1.7 × 10<sup>−10</sup>) and rs4149081 (<em>P</em> = 1.7 × 10<sup>−9</sup>), were in linkage disequilibrium (LD) with each other (<em>r</em><sup>2</sup> = 1) and with a functional polymorphism in <em>SLCO1B1</em>, T521C (rs4149056; <em>r</em><sup>2</sup> &gt; 0.84). rs11045879 and rs4149081 were validated in an independent cohort of 206 patients (<em>P</em> = .018 and <em>P</em> = .017), as were other <em>SLCO1B1</em> SNPs residing in different LD blocks. SNPs in <em>SLCO1B1</em> were also associated with GI toxicity (odds ratio, 15.3 to 16.4; <em>P</em> = .03 to .004).</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Conclusion</h3><p id="__p4" class="p p-first-last">A genome-wide interrogation identified inherited variations in a plausible, yet heretofore low-priority candidate gene, <em>SLCO1B1</em>, as important determinants of methotrexate's pharmacokinetics and clinical effects.</p></div></div></div><div id="__sec5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec5title">INTRODUCTION</h2><p id="__p5" class="p p-first">Whole-genome studies have identified genetic variations associated with risk of complex diseases.<sup><a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243053">1</a>–<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243031">5</a></sup> However, whole-genome pharmacogenetic studies are less common despite considerable speculation that such information will transform drug therapy.<sup><a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243043">6</a>–<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_573340134">10</a></sup> Methotrexate is used to treat malignancies, including acute lymphoblastic leukemia (ALL), as well as autoimmune disorders.<sup><a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243026">11</a>–<a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243007">15</a></sup></p><p id="__p6" class="p p-last">The pharmacologic effects of methotrexate are well characterized, and its systemic exposure has been related to cure and toxicity in childhood ALL<sup><a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243042">16</a>–<a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243024">19</a></sup> and other diseases.<sup><a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243018">20</a>,<a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243010">21</a>,<a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243054">19</a>,<a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243041">22</a>,<a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243019">23</a></sup> The genetic origins of interindividual pharmacokinetic and pharmacodynamic variability of methotrexate remain poorly understood, with conflicting results on candidate pharmacogenetic predictors for methotrexate.<sup><a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243056">24</a>,<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243034">25</a></sup> A genome-wide approach might identify new candidate genes whose polymorphisms forecast which patients might benefit from tailoring dosage on the basis of genomic variation. Herein, we performed a genome-wide association analysis of 434 patients with newly diagnosed ALL and surveyed 500,568 germline single-nucleotide polymorphisms (SNPs).</p></div><div id="__sec6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec6title">PATIENTS AND METHODS</h2><div id="__sec7" class="sec sec-first"><h3 id="__sec7title">Patients and Treatment</h3><p id="__p7" class="p p-first-last">The discovery cohort included 434 children (median age, 5.92 years; range, 1.02 to 18.85 years) with ALL enrolled and treated on St. Jude Children's Research Hospital Total XIIIB and Total XV protocols (Data Supplement Table 1).<sup><a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243046">26</a>–<a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243023">28</a></sup> The validation cohort consisted of the next set of 206 patients (median age, 5.10 years; range 1.17 to 18.67 years) treated on St. Jude's Total XV protocol (Data Supplement Table 1) who were enrolled after the initial analysis began. Total XIIIB included consolidation therapy of two weekly doses of methotrexate (2 g/m<sup>2</sup> over 2 hours, followed by leucovorin) and 6-mercaptopurine (75 mg/m<sup>2</sup> per night for 2 weeks).<sup><a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243045">26</a>,<a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243060">27</a></sup> Subsequent therapy included identical methotrexate and 6-mercaptopurine doses administered every 8 weeks up to 1 year. Total XV included four doses of methotrexate during consolidation, each given over 24 hours with dosage adjusted to achieve a steady-state plasma concentration of 33 μmol/L (low-risk arm) or 65 μmol/L (standard/high-risk arm).<sup><a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243063">28</a></sup> Serum creatinine was measured in the 24 hours before methotrexate treatment. Parents and patients gave informed consent and assent as appropriate, and the study was approved by the institutional review board. All grade 3 and 4 toxicities were prospectively scored using the National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP) (<a href="http://ctep.cancer.gov" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://ctep.cancer.gov</a>) toxicity criteria during the consolidation and continuation periods.<sup><a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243061">26</a></sup> The most common toxicities during consolidation, when only methotrexate and 6-mercaptopurine were given, were GI (mucositis) and infection. Detailed procedures for methotrexate administration (Data Supplement Table 2) and evaluations are provided in the Data Supplement.</p></div><div id="__sec8" class="sec"><h3 id="__sec8title">Pharmacokinetic Data</h3><p id="__p8" class="p p-first-last">Clearance was estimated on the basis of three to four methotrexate plasma concentrations per course up to 48 hours from the start of infusion. Clearance was estimated (CL = k<sub>e</sub> × V) using a two-compartmental linear pharmacokinetic model and a Bayesian approach, via ADAPT software (University of Southern California, Los Angeles, CA), as described.<sup><a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243022">26</a>,<a href="#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243009">29</a>,<a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243038">30</a></sup> Population priors, mean (variance), were 9.0 L/m<sup>2</sup> (22.1) for V<sub>c</sub>, 0.70 hours<sup>−1</sup> (0.05) for K<sub>e</sub>, 0.08 hours<sup>−1</sup> (0.002) for K<sub>cp</sub>, and 0.11 hours<sup>−1</sup> (0.000014) for K<sub>pc</sub> as described.<sup><a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243008">30</a></sup> The average methotrexate clearance per patient across courses was calculated using all available postremission courses.</p></div><div id="__sec9" class="sec"><h3 id="__sec9title">Genotyping and SNP Filtering Criteria</h3><p id="__p9" class="p p-first">Germline DNA was extracted from blood after remission was achieved. DNA (500 ng) was applied to the 500K Array Set (Affymetrix, Santa Clara, CA). Chips were scanned and genotype calls were made using the Bayesian Robust Linear Multichip with Mahalanobis Distance (BRLMM) algorithm for 500,568 interrogated SNPs. Initial missing SNP genotypes were imputed using the fastPHASE software (Data Supplement; University of Washington, Seattle).<sup><a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243051">31</a></sup> SNPs were excluded for genotyping call rates less than 95% (n = 29,314), minor allele frequency less than 1% (n = 63,110), or if allele frequencies deviated from Hardy-Weinberg equilibrium (n = 10,944; <em>P</em> &lt; 1 × 10<sup>−7</sup>). Some SNPs were excluded that met more than one criterion, leaving 398,699 SNPs in the analysis.</p><p id="__p10" class="p p-last">For a subset of patients in the validation cohort (n = 103), SNP genotypes were obtained using Affymetrix Genome-Wide Human SNP Array 6.0 (Affymetrix). The nonsynonymous SNP, <em>SLCO1B1</em> T521C (rs4149056) was not represented on the Affymetrix arrays and was independently genotyped (DNAPrint Genomics, Sarasota, FL); call rates were more than 97% for this SNP.</p></div><div id="__sec10" class="sec sec-last"><h3 id="__sec10title">Statistical Analysis</h3><p id="__p11" class="p p-first">Analyses were conducted using R (<a href="http://www.r-project.org/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.r-project.org/</a>) and SAS (SAS Institute, Cary, NC). Associations between average methotrexate clearance and patient characteristics (sex, age, race, and treatment regimen) were tested using analysis of variance (ANOVA). Nongenetic factors (eg, hydration and alkalinization) were standardized for each treatment regimen (Data Supplement). Associations between germline SNP genotypes and methotrexate clearance were evaluated using a general linear model, treating genotype as a numerical variable (0 = AA, 1 = AB, and 2 = BB) and including age, race, sex, and treatment regimen as covariates. Age was coded in years and treated as a continuous variable. Treatment regimen was coded as a categoric variable, and Total XIIIB was considered the baseline covariate in the multivariate analysis. Ancestry was determined using the actual genotypes, computing each patient's probability of having European, African, or Asian ancestry (Data Supplement). Ancestry was alternatively characterized using Eigenstrat software (Harvard Medical School, Boston, MA) on the basis of a principal component analysis of SNP genotypes.<sup><a href="#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243044">32</a></sup> We found good concordance (94%) between genomically determined ancestry and self-declared race. SNPs whose <em>P</em> value for association with methotrexate clearance was less than 1 × 10<sup>−7</sup> were considered reaching genome-wide significance. Because only SNPs annotated to the <em>SLCO1B1</em> gene were tested for association with methotrexate clearance in the validation cohorts, a <em>P</em> value less than .05 was considered statistically significant. Multiple linear regression analysis was used to estimate percent variation explained by genotypes and other covariates.</p><p id="__p12">A genome-wide linear mixed effect model<sup><a href="#B33" rid="B33" class=" bibr popnode">33</a></sup> was also conducted with each individual course of methotrexate clearance as a dependent variable, including course number (course 1 to 10 for patients on Total XIIIB and course 1 to 4 for patients on Total XV) and serum creatinine for each course as covariates. A linear mixed effect model was also used to estimate the intra- and interpatient variability in methotrexate clearance in the discovery cohort.</p><p id="__p13">Logistic regression was used to analyze whether <em>SLCO1B1</em> genotypes were associated with toxicity (GI toxicity and infection) as a dichotomous variable (yes or no) during consolidation. Patients with grade 3 or 4 toxicities (mucositis or infection) were considered as having toxicity. Weighted logistic regression<sup><a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243020">26</a></sup> was used to analyze the genotype-toxicity association in the 120-week continuation phase of therapy for Total XIIIB, accounting for recurrent episodes and censoring. The cumulative incidences of GI toxicity were compared among genotypes using Gray's test with incorporation of competing risks.<sup><a href="#B34" rid="B34" class=" bibr popnode">34</a></sup> To compute the odds ratio estimated for toxicity during the consolidation phase of therapy, we added a continuity adjustment of 0.5 to each cell count to deal with the zero event count for those with common homozygous genotypes.</p><p id="__p14" class="p p-last">For the gene level analysis, 24,836 genes were annotated to the interrogated SNPs, including all SNPs located within 5,000 base pairs (ie, <em>cis</em>-SNPs) of each transcript. We tested for significant associations between all the SNP genotypes (per gene) and methotrexate clearance using multiple linear regression, and we assessed the percent variation explained by the genotypes using <em>r</em><sup>2</sup> test statistic, the Akaike information criterion, and permutation analyses (Data Supplement).</p></div></div><div id="__sec11" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec11title">RESULTS</h2><p id="__p15" class="p p-first">In the discovery cohort, we estimated methotrexate clearance for 3,014 treatment courses given to 434 patients (Data Supplement Table 1). There was substantial interpatient variability in average (± standard deviation) methotrexate clearance (<a href="/pmc/articles/PMC2793040/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig 1</span></a>), which differed among the 213 patients on the Total XIIIB (133 ± 25 mL/min/m<sup>2</sup>), the 114 patients on the Total XV low-risk (123 ± 28 mL/min/m<sup>2</sup>), and the 107 patients on the Total XV standard/high-risk (106 ± 22 mL/min/m<sup>2</sup>) treatment regimens (Data Supplement Fig 1; <em>P</em> &lt; 2.2 × 10<sup>−16</sup>). The variability observed between treatment regimens is not surprising, given that dosage and the concomitant hydration and alkalinization (factors that can affect methotrexate clearance) differed (Data Supplement Table 2).<sup><a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243047">22</a></sup> Average methotrexate clearance differed by ancestral group (Data Supplement Fig 2; <em>P</em> = .005) with African American patients having the highest clearance. As previously noted,<sup><a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243048">19</a>,<a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243035">22</a></sup> methotrexate clearance decreased with increasing age (Data Supplement Fig 3; <em>P</em> = 1.1 × 10<sup>-6</sup>). Thus, we adjusted all analyses for age, race, sex, and treatment regimen. Using a linear mixed effect model, the intrapatient variability in methotrexate clearance was 48%, while the interpatient variability was 52%.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC2793040/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140305983131376" class="figure"><a href="/pmc/articles/PMC2793040/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2793040_zlj9990990890001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is zlj9990990890001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2793040/bin/zlj9990990890001.jpg"></a></div><div id="largeobj_idm140305983131376" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2793040/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC2793040/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Fig 1.</a></div><!--caption a7--><div class="caption"><p id="__p16">Average methotrexate clearance and linkage disequilibrium structure of the <em>SLCO1B1</em> single-nucleotide polymorphisms (SNPs) in 434 children with acute lymphoblastic leukemia. The average methotrexate clearance for each of the 434 children in the discovery cohort is plotted from the highest to lowest (gray shaded area), and each patient's genotype at each of the <em>SLCO1B1</em> SNP loci listed is indicated (colored bars below the x axis). Patients homozygous for the major allele are coded in blue, heterozygotes are coded in green, and those homozygous for the minor allele are coded in yellow.</p></div></div></div><p id="__p17">We tested the association between 398,699 SNPs and average methotrexate clearance in 434 children in the discovery cohort. The strongest association signal was on chromosome 12 (<a href="/pmc/articles/PMC2793040/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig 2</span></a>). The two top SNPs associated with methotrexate clearance were annotated to the transporter gene, <em>SLCO1B1</em>/OATP1B1, located on chromosome 12 (<a href="/pmc/articles/PMC2793040/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>; Data Supplement Tables 3-5). These two <em>SLCO1B1</em> SNPs remained significant (rs11045879, <em>P</em> = 1.7 × 10<sup>−10</sup> and rs4149081, <em>P</em> = 1.7 × 10<sup>−9</sup>) even after correction for multiple testing. These two <em>SLCO1B1</em> SNPs were in complete LD (<em>r</em><sup>2</sup> = 1) with each other (<a href="/pmc/articles/PMC2793040/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig 1</span></a>) and were associated with methotrexate clearance across regimens (<a href="/pmc/articles/PMC2793040/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig 3</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC2793040/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140305981395088" class="figure"><a href="/pmc/articles/PMC2793040/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2793040_zlj9990990890002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is zlj9990990890002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2793040/bin/zlj9990990890002.jpg"></a></div><div id="largeobj_idm140305981395088" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2793040/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC2793040/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Fig 2.</a></div><!--caption a7--><div class="caption"><p id="__p18">Genome-wide <em>P</em> values showing the association of single-nucleotide polymorphisms (SNPs) with methotrexate clearance in the discovery cohort of 434 children with acute lymphoblastic leukemia. Shown is the distribution of <em>P</em> values (as –log<sub>10</sub> values) for the association of 398,699 SNP genotypes with methotrexate clearance in the discovery cohort. The <em>P</em> value of 1.7 × 10<sup>−10</sup> is for the most significant association identified between a single SNP (located in <em>SLCO1B1</em> on chromosome 12) and methotrexate clearance.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1.</h3><!--caption a7--><div class="caption"><p id="__p19"><em>SLCO1B1</em> SNPs and Methotrexate Clearance</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140305978164416" class="xtable"><table frame="box" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr><th rowspan="2" colspan="1" align="center">dbSNP ID</th><th rowspan="2" colspan="1" align="center">Location</th><th rowspan="2" colspan="1" align="center">Genomic Position</th><th rowspan="2" colspan="1" align="center">Alleles (A/B)</th><th colspan="4" rowspan="1" align="center">Discovery Cohort (n = 434)<hr></th><th colspan="4" rowspan="1" align="center">Validation Cohort (n = 206)<hr></th><th colspan="4" rowspan="1" align="center">Combined Cohort (n = 640)<hr></th></tr><tr><th rowspan="1" colspan="1" align="center">MAF</th><th rowspan="1" colspan="1" align="center">Coefficient<sup>*</sup></th><th rowspan="1" colspan="1" align="center">95% CI</th><th rowspan="1" colspan="1" align="center"><em>P</em></th><th rowspan="1" colspan="1" align="center">MAF</th><th rowspan="1" colspan="1" align="center">Coefficient<sup>*</sup></th><th rowspan="1" colspan="1" align="center">95% CI</th><th rowspan="1" colspan="1" align="center"><em>P</em></th><th rowspan="1" colspan="1" align="center">MAF</th><th rowspan="1" colspan="1" align="center">Coefficient<sup>*</sup></th><th rowspan="1" colspan="1" align="center">95% CI</th><th rowspan="1" colspan="1" align="center"><em>P</em></th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left">rs11045879</td><td rowspan="1" colspan="1" align="left">Intron</td><td rowspan="1" colspan="1" align="center">21273886</td><td rowspan="1" colspan="1" align="left">C/T</td><td rowspan="1" colspan="1" align="center">0.17</td><td rowspan="1" colspan="1" align="center">13.1</td><td rowspan="1" colspan="1" align="center">9.1 to 17.1</td><td rowspan="1" colspan="1" align="center">1.7 × 10<sup>−10</sup></td><td rowspan="1" colspan="1" align="center">0.17</td><td rowspan="1" colspan="1" align="center">6.05</td><td rowspan="1" colspan="1" align="center">1.0 to 10.9</td><td rowspan="1" colspan="1" align="center">.018</td><td rowspan="1" colspan="1" align="center">0.16</td><td rowspan="1" colspan="1" align="center">10.8</td><td rowspan="1" colspan="1" align="center">7.6 to 14.0</td><td rowspan="1" colspan="1" align="center">8.2 × 10<sup>−11</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">rs4149081</td><td rowspan="1" colspan="1" align="left">Intron</td><td rowspan="1" colspan="1" align="center">21269288</td><td rowspan="1" colspan="1" align="left">A/G</td><td rowspan="1" colspan="1" align="center">0.16</td><td rowspan="1" colspan="1" align="center">12.7</td><td rowspan="1" colspan="1" align="center">8.5 to 16.8</td><td rowspan="1" colspan="1" align="center">1.7 × 10<sup>−9</sup></td><td rowspan="1" colspan="1" align="center">0.17</td><td rowspan="1" colspan="1" align="center">6.16</td><td rowspan="1" colspan="1" align="center">1.1 to 11.1</td><td rowspan="1" colspan="1" align="center">.017</td><td rowspan="1" colspan="1" align="center">0.16</td><td rowspan="1" colspan="1" align="center">10.4</td><td rowspan="1" colspan="1" align="center">7.2 to 13.7</td><td rowspan="1" colspan="1" align="center">6.7 × 10<sup>−10</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">rs11045818</td><td rowspan="1" colspan="1" align="left">Synonymous</td><td rowspan="1" colspan="1" align="center">21221028</td><td rowspan="1" colspan="1" align="left">A/G</td><td rowspan="1" colspan="1" align="center">0.14</td><td rowspan="1" colspan="1" align="center">−9.2</td><td rowspan="1" colspan="1" align="center">−13.8 to −4.5</td><td rowspan="1" colspan="1" align="center">2.2 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" align="center">0.13</td><td rowspan="1" colspan="1" align="center">−11.7</td><td rowspan="1" colspan="1" align="center">−17.1 to −6.3</td><td rowspan="1" colspan="1" align="center">3.7 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" align="center">0.14</td><td rowspan="1" colspan="1" align="center">−9.3</td><td rowspan="1" colspan="1" align="center">−12.9 to −5.7</td><td rowspan="1" colspan="1" align="center">6.3 × 10<sup>−7</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">rs10841753</td><td rowspan="1" colspan="1" align="left">Intron</td><td rowspan="1" colspan="1" align="center">21212637</td><td rowspan="1" colspan="1" align="left">C/T</td><td rowspan="1" colspan="1" align="center">0.20</td><td rowspan="1" colspan="1" align="center">−7.8</td><td rowspan="1" colspan="1" align="center">−11.7 to −3.8</td><td rowspan="1" colspan="1" align="center">1.3 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" align="center">0.15</td><td rowspan="1" colspan="1" align="center">−7.1</td><td rowspan="1" colspan="1" align="center">−11.8 to −2.3</td><td rowspan="1" colspan="1" align="center">.004</td><td rowspan="1" colspan="1" align="center">0.19</td><td rowspan="1" colspan="1" align="center">−7.1</td><td rowspan="1" colspan="1" align="center">−10.2 to −4.0</td><td rowspan="1" colspan="1" align="center">8.6 × 10<sup>−6</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">rs11045872</td><td rowspan="1" colspan="1" align="left">Intron</td><td rowspan="1" colspan="1" align="center">21263611</td><td rowspan="1" colspan="1" align="left">A/G</td><td rowspan="1" colspan="1" align="center">0.16</td><td rowspan="1" colspan="1" align="center">8.1</td><td rowspan="1" colspan="1" align="center">3.7 to 12.5</td><td rowspan="1" colspan="1" align="center">5.0 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" align="center">0.15</td><td rowspan="1" colspan="1" align="center">7.1</td><td rowspan="1" colspan="1" align="center">2.0 to 12.2</td><td rowspan="1" colspan="1" align="center">.007</td><td rowspan="1" colspan="1" align="center">0.16</td><td rowspan="1" colspan="1" align="center">7.3</td><td rowspan="1" colspan="1" align="center">3.9 to 10.7</td><td rowspan="1" colspan="1" align="center">3.4 × 10<sup>−5</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">rs2900476</td><td rowspan="1" colspan="1" align="left">Intron</td><td rowspan="1" colspan="1" align="center">21227330</td><td rowspan="1" colspan="1" align="left">C/T</td><td rowspan="1" colspan="1" align="center">0.23</td><td rowspan="1" colspan="1" align="center">6.5</td><td rowspan="1" colspan="1" align="center">2.8 to 10.2</td><td rowspan="1" colspan="1" align="center">6.0 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" align="center">0.26</td><td rowspan="1" colspan="1" align="center">2.5</td><td rowspan="1" colspan="1" align="center">−2.0 to 7.0</td><td rowspan="1" colspan="1" align="center">.27</td><td rowspan="1" colspan="1" align="center">0.24</td><td rowspan="1" colspan="1" align="center">5.0</td><td rowspan="1" colspan="1" align="center">2.1 to 7.9</td><td rowspan="1" colspan="1" align="center">.000796</td></tr><tr><td rowspan="1" colspan="1" align="left">rs17328763</td><td rowspan="1" colspan="1" align="left">5′ upstream</td><td rowspan="1" colspan="1" align="center">21173837</td><td rowspan="1" colspan="1" align="left">C/T</td><td rowspan="1" colspan="1" align="center">0.15</td><td rowspan="1" colspan="1" align="center">−6.1</td><td rowspan="1" colspan="1" align="center">−10.6 to −1.6</td><td rowspan="1" colspan="1" align="center">.01</td><td rowspan="1" colspan="1" align="center">0.17</td><td rowspan="1" colspan="1" align="center">−5.4</td><td rowspan="1" colspan="1" align="center">−10.4 to −0.4</td><td rowspan="1" colspan="1" align="center">.034</td><td rowspan="1" colspan="1" align="center">0.15</td><td rowspan="1" colspan="1" align="center">−5.3</td><td rowspan="1" colspan="1" align="center">−8.7 to −1.9</td><td rowspan="1" colspan="1" align="center">.002676</td></tr><tr><td rowspan="1" colspan="1" align="left">rs11045787</td><td rowspan="1" colspan="1" align="left">Intron</td><td rowspan="1" colspan="1" align="center">21191269</td><td rowspan="1" colspan="1" align="left">G/T</td><td rowspan="1" colspan="1" align="center">0.15</td><td rowspan="1" colspan="1" align="center">−5.9</td><td rowspan="1" colspan="1" align="center">−10.4 to −1.4</td><td rowspan="1" colspan="1" align="center">.01</td><td rowspan="1" colspan="1" align="center">0.16</td><td rowspan="1" colspan="1" align="center">−5.5</td><td rowspan="1" colspan="1" align="center">−10.5 to −0.4</td><td rowspan="1" colspan="1" align="center">.034</td><td rowspan="1" colspan="1" align="center">0.15</td><td rowspan="1" colspan="1" align="center">−5.2</td><td rowspan="1" colspan="1" align="center">−8.6 to −1.7</td><td rowspan="1" colspan="1" align="center">.003227</td></tr><tr><td rowspan="1" colspan="1" align="left">rs4149076</td><td rowspan="1" colspan="1" align="left">Intron</td><td rowspan="1" colspan="1" align="center">21262411</td><td rowspan="1" colspan="1" align="left">C/T</td><td rowspan="1" colspan="1" align="center">0.32</td><td rowspan="1" colspan="1" align="center">4.4</td><td rowspan="1" colspan="1" align="center">0.9 to 7.9</td><td rowspan="1" colspan="1" align="center">.01</td><td rowspan="1" colspan="1" align="center">0.32</td><td rowspan="1" colspan="1" align="center">−0.4</td><td rowspan="1" colspan="1" align="center">−4.3 to 3.6</td><td rowspan="1" colspan="1" align="center">.85</td><td rowspan="1" colspan="1" align="center">0.32</td><td rowspan="1" colspan="1" align="center">2.9</td><td rowspan="1" colspan="1" align="center">0.2 to 5.6</td><td rowspan="1" colspan="1" align="center">.033823</td></tr><tr><td rowspan="1" colspan="1" align="left">rs7966613</td><td rowspan="1" colspan="1" align="left">intron</td><td rowspan="1" colspan="1" align="center">21270899</td><td rowspan="1" colspan="1" align="left">A/G</td><td rowspan="1" colspan="1" align="center">0.32</td><td rowspan="1" colspan="1" align="center">−3.6</td><td rowspan="1" colspan="1" align="center">−7.0 to −0.1</td><td rowspan="1" colspan="1" align="center">.03</td><td rowspan="1" colspan="1" align="center">0.33</td><td rowspan="1" colspan="1" align="center">0.8</td><td rowspan="1" colspan="1" align="center">−3.1 to 4.8</td><td rowspan="1" colspan="1" align="center">.67</td><td rowspan="1" colspan="1" align="center">0.32</td><td rowspan="1" colspan="1" align="center">−2.3</td><td rowspan="1" colspan="1" align="center">−5.0 to 0.4</td><td rowspan="1" colspan="1" align="center">.093071</td></tr></tbody></table></div><div id="largeobj_idm140305978164416" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC2793040/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm140305981780656"><p id="__p20" class="p p-first-last">Abbreviations: SNP, single-nucleotide polymorphism; dbSNP, SNP database; ID, identification; MAF, minor allele frequency.</p></div><div id="TF1-1"><sup>*</sup>The coefficient or effect size represents the increase (positive value) or decrease (negative value) in methotrexate clearance (mL/min/m<sup>2</sup>) for those patients who carry an additional B allele at the SNP locus listed. For instance, methotrexate clearance for patients in the discovery cohort who carry the T allele at the rs11045879 locus will have higher methotrexate clearance (+13.1 mL/min/m<sup>2</sup> higher) than those patients that carry the C allele. For each additional T allele, methotrexate clearance will increase on average 13.1 mL/min/m<sup>2</sup>.</div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC2793040/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140305983232560" class="figure"><a href="/pmc/articles/PMC2793040/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2793040_zlj9990990890003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is zlj9990990890003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2793040/bin/zlj9990990890003.jpg"></a></div><div id="largeobj_idm140305983232560" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2793040/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC2793040/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Fig 3.</a></div><!--caption a7--><div class="caption"><p id="__p22"><em>SLCO1B1</em> single-nucleotide polymorphism (SNP) rs11045879 is associated with methotrexate clearance and GI toxicity. (A) Association of <em>SLCO1B1</em> SNP genotype (rs11045879) with methotrexate clearance in patients on Total XIIIB (TXIIIB), Total XV low-risk (TXVL), and Total XV standard/high-risk (TXVSH) treatment regimens. Numbers below each box plot indicate the sample size for each genotype. (B) Association of this SNP with GI toxicity. Logistic regression was used to analyze whether genotypes for <em>SLCO1B1</em> SNPs were associated with toxicity as a dichotomous variable (yes or no) during the 2-week consolidation phase. The bar graphs display the percentage of patients (plotted on the y axis) per genotype (plotted on the x axis) who had grade 3 to 4 GI toxicity. Numbers above each bar represent the number of patients who had toxicity versus those who did not for the specified genotype. Similar relationships exist for <em>SLCO1B1</em> SNP rs4149081 (data not shown).</p></div></div></div><p id="__p23">We also used a linear mixed effects model to identify associations between SNP genotypes and methotrexate clearance; the results were similar to those assessing average clearance, with the same two top-ranked SNPs (<em>P</em> &lt; 6.8 × 10<sup>−9</sup>) in <em>SLCO1B1</em> (Data Supplement Table 4). Only 6.0% of the intracourse variability in clearance was accounted for by course number, even when accounting for the premethotrexate serum creatinine (Data Supplement Table 6).</p><p id="__p24">Eight additional <em>SLCO1B1</em> SNPs (<a href="/pmc/articles/PMC2793040/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>) were associated with clearance (<em>P</em> &lt; .05); these SNPs were not in LD (based on <em>r</em><sup>2</sup>) with the top two <em>SLCO1B1</em> SNPs (<a href="/pmc/articles/PMC2793040/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig 1</span></a>) and were encompassed by multiple haplotype blocks (Data Supplement Figs 4A and <a href="/pmc/articles/PMC2793040/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -1.5em;">and4B).</span></span><span>4</span></a>B). In a gene-level analysis, <em>SLCO1B1</em> had a stronger association with methotrexate clearance (<em>P</em> &lt; 1 × 10<sup>−6</sup>), with a higher <em>r</em><sup>2</sup> and a lower Akaike information criterion, than any other gene (Data Supplement Tables 7 and 11).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC2793040/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140306015609104" class="figure"><a href="/pmc/articles/PMC2793040/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2793040_zlj9990990890004.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is zlj9990990890004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2793040/bin/zlj9990990890004.jpg"></a></div><div id="largeobj_idm140306015609104" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2793040/figure/F4/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC2793040/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Fig 4.</a></div><!--caption a7--><div class="caption"><p id="__p37">Incidence of toxicity based on <em>SLCO1B1</em> rs11045879 genotype. Cumulative incidence of the first episode of GI toxicity significantly differed (<em>P</em> = .024) by <em>SLCO1B1</em> rs11045879 genotype during the continuation phase of treatment during the Total XIIIB treatment regimen. Cumulative incidences of GI toxicity were compared among genotypes using Gray's test with incorporation of competing risks.</p></div></div></div><p id="__p25">We genotyped a validation cohort of 206 additional patients (<a href="/pmc/articles/PMC2793040/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). Seven of the 10 interrogated <em>SLCO1B1</em> SNPs remained associated (<em>P</em> &lt; .05) with methotrexate clearance (<a href="/pmc/articles/PMC2793040/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). Nine of the 10 <em>SLCO1B1</em> SNPs were associated with clearance (<em>P</em> &lt; .05) when the two cohorts (discovery and validation) were combined (<a href="/pmc/articles/PMC2793040/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>), and the strongest signal remained in <em>SLCO1B1</em> (Data Supplement Fig 5).</p><p id="__p26">The percentage of methotrexate clearance variability that could be explained by <em>SLCO1B1</em> genotypes compared with the variability explained by factors such as race, sex, age, treatment regimen, or serum creatinine was estimated in a multivariate analysis for both the discovery and validation cohorts (<a href="/pmc/articles/PMC2793040/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). In a stepwise linear regression analysis, five SNPs were retained in the model (<a href="/pmc/articles/PMC2793040/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>), such that <em>SLCO1B1</em> genetic variation accounted for 9.3% of the interpatient variability in the discovery cohort and 11.3% in the validation cohort. This superseded the proportion of variability contributed by the significant factors of race, serum creatinine, and sex; only treatment regimen accounted for a higher proportion (17.9%) of the variation in clearance (<a href="/pmc/articles/PMC2793040/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). Average serum creatinine concentrations explained 3.2% and 1.9% of the variability in methotrexate clearance in the discovery and validation cohorts, respectively; in a linear mixed effects model (Data Supplement Table 6), 2.4% of interpatient and 0.4% of intrapatient variability was accounted for by serum creatinine. Treatment regimen and <em>SLCO1B1</em> SNP genotypes accounted for 18.6% and 11.0% of variability in clearance, respectively. Results were similar for the first cycle only of methotrexate (Data Supplement Table 8).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2.</h3><!--caption a7--><div class="caption"><p id="__p27">Multivariate Analysis of Factors Associated With Average Methotrexate Clearance in the Discovery and Validation Cohorts</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140305981499664" class="xtable"><table frame="box" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr><th rowspan="2" colspan="1" align="center">Variables</th><th colspan="4" rowspan="1" align="center">Discovery Cohort (n = 434)<hr></th><th colspan="4" rowspan="1" align="center">Validation Cohort With Serum Creatinine Data<sup>*</sup>(n = 125)<hr></th><th colspan="4" rowspan="1" align="center">Validation Cohort<sup>†</sup> (n = 206)<hr></th></tr><tr><th rowspan="1" colspan="1" align="center">Coefficient<sup>‡</sup></th><th rowspan="1" colspan="1" align="center">95% CI</th><th rowspan="1" colspan="1" align="center"><em>P</em><sup>§</sup></th><th rowspan="1" colspan="1" align="center"><em>r</em><sup>2</sup> (%)</th><th rowspan="1" colspan="1" align="center">Coefficient<sup>‡</sup></th><th rowspan="1" colspan="1" align="center">95% CI</th><th rowspan="1" colspan="1" align="center"><em>P</em><sup>§</sup></th><th rowspan="1" colspan="1" align="center"><em>r</em><sup>2</sup> (%)</th><th rowspan="1" colspan="1" align="center">Coefficient<sup>‡</sup></th><th rowspan="1" colspan="1" align="center">95% CI</th><th rowspan="1" colspan="1" align="center"><em>P</em><sup>§</sup></th><th rowspan="1" colspan="1" align="center"><em>r</em><sup>2</sup> (%)</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left">Ancestry<sup>¶</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.0007</td><td rowspan="1" colspan="1" align="center">2.1</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.32</td><td rowspan="1" colspan="1" align="center">1.6</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.021</td><td rowspan="1" colspan="1" align="center">4.1</td></tr><tr><td rowspan="1" colspan="1" align="left">    African</td><td rowspan="1" colspan="1" align="center">Ref<sup>‡</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">Ref<sup>‡</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">Ref<sup>‡</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    European</td><td rowspan="1" colspan="1" align="center">−13.0</td><td rowspan="1" colspan="1" align="center">−19.8 to −6.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">−7.9</td><td rowspan="1" colspan="1" align="center">−18.5 to 2.8</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">−7.3</td><td rowspan="1" colspan="1" align="center">−16.7 to 2.0</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    Asian</td><td rowspan="1" colspan="1" align="center">−6.5</td><td rowspan="1" colspan="1" align="center">−25.0 to 12.0</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">2.4</td><td rowspan="1" colspan="1" align="center">−31.8 to 36.6</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">14.6</td><td rowspan="1" colspan="1" align="center">−4.3 to 33.6</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">Sex</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.003</td><td rowspan="1" colspan="1" align="center">0.01</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.02</td><td rowspan="1" colspan="1" align="center">3.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.046</td><td rowspan="1" colspan="1" align="center">1.1</td></tr><tr><td rowspan="1" colspan="1" align="left">    Female</td><td rowspan="1" colspan="1" align="center">Ref<sup>‡</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">Ref<sup>‡</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">Ref<sup>‡</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    Male</td><td rowspan="1" colspan="1" align="center">6.6</td><td rowspan="1" colspan="1" align="center">2.2 to 10.9</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">7.7</td><td rowspan="1" colspan="1" align="center">1.1 to 14.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">5.6</td><td rowspan="1" colspan="1" align="center">0.2 to 11.0</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">Serum creatinine, mg/dL<sup>‖</sup></td><td rowspan="1" colspan="1" align="center">−60.2</td><td rowspan="1" colspan="1" align="center">−86.8 to −33.7</td><td rowspan="1" colspan="1" align="center">8.6 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">3.2</td><td rowspan="1" colspan="1" align="center">−33.6</td><td rowspan="1" colspan="1" align="center">−71.8 to 4.6</td><td rowspan="1" colspan="1" align="center">.09</td><td rowspan="1" colspan="1" align="center">1.9</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">NA</td></tr><tr><td rowspan="1" colspan="1" align="left">Age, years</td><td rowspan="1" colspan="1" align="center">0.39</td><td rowspan="1" colspan="1" align="center">−0.49 to 1.3</td><td rowspan="1" colspan="1" align="center">.39</td><td rowspan="1" colspan="1" align="center">0.1</td><td rowspan="1" colspan="1" align="center">0.98</td><td rowspan="1" colspan="1" align="center">−0.21 to 2.2</td><td rowspan="1" colspan="1" align="center">.10</td><td rowspan="1" colspan="1" align="center">1.7</td><td rowspan="1" colspan="1" align="center">−0.5</td><td rowspan="1" colspan="1" align="center">−1.1 to 0.1</td><td rowspan="1" colspan="1" align="center">.093</td><td rowspan="1" colspan="1" align="center">1.7</td></tr><tr><td rowspan="1" colspan="1" align="left">Treatment regimen</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">1.1 × 10<sup>−25</sup></td><td rowspan="1" colspan="1" align="center">17.9</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.00013</td><td rowspan="1" colspan="1" align="center">9.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.001</td><td rowspan="1" colspan="1" align="center">2.8</td></tr><tr><td rowspan="1" colspan="1" align="left">    Total XV low-risk</td><td rowspan="1" colspan="1" align="center">Ref<sup>‡</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">Ref<sup>‡</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">Ref<sup>‡</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    Total XV standard/high-risk</td><td rowspan="1" colspan="1" align="center">−15.9</td><td rowspan="1" colspan="1" align="center">−22.1 to −9.7</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">−15.0</td><td rowspan="1" colspan="1" align="center">−22.8 to −7.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">−7.2</td><td rowspan="1" colspan="1" align="center">−13.1 to −1.4</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    Total XIIIB</td><td rowspan="1" colspan="1" align="center">14.3</td><td rowspan="1" colspan="1" align="center">8.7 to 19.8</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left"><em>SLCO1B1</em> genotype<sup>#</sup></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">2.3 × 10<sup>−10</sup></td><td rowspan="1" colspan="1" align="center">9.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">.002</td><td rowspan="1" colspan="1" align="center">11.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">4.7 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" align="center">9.3</td></tr><tr><td rowspan="1" colspan="1" align="left">    rs4149081 (A/G)</td><td rowspan="1" colspan="1" align="center">14.0</td><td rowspan="1" colspan="1" align="center">8.5 to 19.5</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">5.2</td><td rowspan="1" colspan="1" align="center">−3.3 to 13.8</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">6.6</td><td rowspan="1" colspan="1" align="center">0 to 13.2</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    rs10841753 (C/T)</td><td rowspan="1" colspan="1" align="center">−7.2</td><td rowspan="1" colspan="1" align="center">−13.6 to −0.8</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">0.07</td><td rowspan="1" colspan="1" align="center">−12.1 to 12.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">1.3</td><td rowspan="1" colspan="1" align="center">−6.8 to 9.4</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    rs11045818 (A/G)</td><td rowspan="1" colspan="1" align="center">−8.3</td><td rowspan="1" colspan="1" align="center">−19.4 to −2.9</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">−18.6</td><td rowspan="1" colspan="1" align="center">−34.7 to −2.4</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">−17.8</td><td rowspan="1" colspan="1" align="center">−29.7 to −5.8</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    rs2900476 (C/T)</td><td rowspan="1" colspan="1" align="center">3.4</td><td rowspan="1" colspan="1" align="center">−1.6 to 8.4</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">3.4</td><td rowspan="1" colspan="1" align="center">−4.2 to 11.0</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">2.9</td><td rowspan="1" colspan="1" align="center">−3.1 to 8.9</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1" align="left">    rs17328763 (C/T)</td><td rowspan="1" colspan="1" align="center">−8.4</td><td rowspan="1" colspan="1" align="center">−18.5 to 1.6</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">−6.0</td><td rowspan="1" colspan="1" align="center">−17.4 to 5.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1" align="center">−6.2</td><td rowspan="1" colspan="1" align="center">−14.7 to 2.1</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm140305981499664" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC2793040/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm140305981246816"><p id="__p28" class="p p-first-last">Abbreviation: NA, Not applicable.</p></div><div id="TF2-1"><sup>*</sup>Results from a multivariate analysis in patients from the validation cohort who had evaluable serum creatinine levels available, n = 125. Eighty-one patients (of 206) had missing serum creatinine values.</div><div id="TF2-2"><sup>†</sup>Results from a multivariate analysis in the validation cohort without including serum creatinine as a covariate, n = 206.</div><div id="TF2-3"><sup>‡</sup>The coefficient or effect size represents the increase (positive value) or decrease (negative value) in methotrexate clearance (mL/min/m<sup>2</sup>) for each variable listed. For example in the discovery cohort, for a patient whose ancestry is 100% European, methotrexate clearance will decrease 13.0 mL/min/m<sup>2</sup> relative to someone whose ancestry is 100% African. Similarly, males will have methotrexate clearance that is 6.6 mL/min/m<sup>2</sup> higher than that of females. A patient with the G allele at rs4149081 would have a clearance of 14 mL/min/m<sup>2</sup> higher than a patient with the A allele. Ref denotes the baseline or reference variable in the multiple linear regression model.</div><div id="TF2-4"><sup>§</sup>The <em>P</em> value is derived from the χ<sup>2</sup> test comparing the deviance of the full model including all variables (eg, <em>SLCO1B1</em> SNP genotypes, ancestry, sex, age) versus the model excluding each variable one at a time.</div><div id="TF2-5"><sup>¶</sup>Ancestry was determined using SNP genotypes from the 500-K mapping array set as described in Patients and Methods and the Data Supplement.</div><div id="TF2-6"><sup>‖</sup>The average serum creatinine concentration (mg/dL) was used as a measure for renal function and was included in the multivariate analysis.</div><div id="TF2-7"><sup>#</sup>Patients who carry the B allele (A/B) will have an increase or decrease in clearance based on the sign of the coefficient listed.</div></div></div><p id="__p36">GI toxicity (grade 3 or 4 mucositis) and infection were the most common toxicities observed during the methotrexate-intensive consolidation and continuation phases of Total XIIIB therapy.<sup><a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243027">26</a></sup> SNPs in <em>SLCO1B1</em>, rs11045879 T allele (OR, 16.4; 95% CI, 8.7 to 26.7; <em>P</em> = .004) and the G allele at rs4149081 (OR, 15.3; 95% CI, 7.9 to 24.6; <em>P</em> = .03; data not shown) were each associated with GI toxicity during consolidation (<a href="/pmc/articles/PMC2793040/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig 3</span></a>). The same two SNPs were also associated with GI toxicity during the continuation phase (<a href="/pmc/articles/PMC2793040/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig 4</span></a>). During the consolidation phase of Total XV, GI toxicity was less frequent (5% <em>v</em> 18% in Total XIIIB), and we found no association with <em>SLCO1B1</em> SNP genotypes. Because all patients on Total XV had their methotrexate doses adjusted to achieve a common steady-state plasma concentration, relationships among toxicity and methotrexate exposure and <em>SLCO1B1</em> SNPs may have been attenuated on this trial. We found no associations between <em>SLCO1B1</em> SNP genotype and infectious toxicity in either trial (data not shown).</p><p id="__p38" class="p p-last">We also genotyped the nonsynonymous <em>SLCO1B1</em> T521C (rs4149056) polymorphism in a subset of 489 patients; this subset included 387 patients from the discovery cohort and 102 patients from the validation cohort (Data Supplement Table 1). <em>SLCO1B1</em> T521C was in high LD with the top <em>SLCO1B1</em> SNPs rs11045879 (<em>r</em><sup>2</sup> = 0.86, discovery cohort; <em>r</em><sup>2</sup> = 0.89, validation cohort) and rs4149081 (<em>r</em><sup>2</sup> = 0.86, discovery cohort; <em>r</em><sup>2</sup> = 0.89, validation cohort). <em>SLCO1B1</em> T521C was associated with methotrexate clearance in the discovery and the combined (discovery plus validation) patient cohorts (Data Supplement Table 9; <em>P</em> = 1.9 × 10<sup>−7</sup> and <em>P</em> = 1.2 × 10<sup>−7</sup>, respectively). In addition, a marginal association (<em>P</em> = .07) was observed between this SNP genotype and the occurrence of GI toxicity during consolidation (Data Supplement Fig 6). In multivariate analysis, the T521C SNP was significantly associated with methotrexate clearance; however, when genotypes at T521C and at rs11045879 were allowed to compete, only the rs11045879 SNP remained in the model (Data Supplement Table 10).</p></div><div id="__sec12" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec12title">DISCUSSION</h2><p id="__p39" class="p p-first">Using a genome-wide interrogation of germline variation, we uncovered genetic variation that affects the disposition and effects of methotrexate in children with ALL. The strongest genetic variation associated with methotrexate pharmacokinetics and dynamics resided in a reasonable candidate gene, <em>SLCO1B1</em>, although this transporter was not previously studied as a candidate gene in clinical pharmacogenetic studies of methotrexate.<sup><a href="#B35" rid="B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243030">35</a>–<a href="#B38" rid="B38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243029">38</a></sup></p><p id="__p40">The <em>SLCO1B1</em> locus maintained significance after adjusting for covariates such as age, race, serum creatinine, sex, and treatment regimen and was verified in an independent validation set. The top-ranked SNPs (Data Supplement Tables 3-5), rs11045879 and rs4149081, were located in the gene (<em>SLCO1B1</em>) encoding an organic anion transporter (OATP1B1). Eight additional SNPs in <em>SLCO1B1</em> had <em>P</em> values less than .05 for their association with methotrexate clearance (<a href="/pmc/articles/PMC2793040/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). The fact that multiple SNPs in this locus, some of which were not in LD, were independently associated with methotrexate clearance provides further evidence of the functional importance of <em>SLCO1B1</em>.</p><p id="__p41"><em>SLCO1B1</em> is localized at the sinusoidal membrane of hepatocytes, and its transcript has been detected in enterocytes.<sup><a href="#B39" rid="B39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243033">39</a>–<a href="#B41" rid="B41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243013">41</a></sup> <em>SLCO1B1</em> mediates uptake of substrates from sinusoidal blood, resulting in their net excretion from blood (likely via biliary excretion). <em>SLCO1B1</em> has been shown to transport methotrexate in vitro,<sup><a href="#B42" rid="B42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243059">42</a>,<a href="#B43" rid="B43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243052">43</a></sup> as well as other compounds such as bilirubin, bile acids, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors,<sup><a href="#B44" rid="B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243037">44</a>,<a href="#B45" rid="B45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243058">45</a></sup> benzylpenicillin, rifampicin, angiotensin-converting enzyme inhibitors, and the active metabolite of irinotecan, SN-38.<sup><a href="#B46" rid="B46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243017">46</a>,<a href="#B47" rid="B47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243062">47</a></sup></p><p id="__p42">Previous studies have described functional consequences of nonsynonymous polymorphisms in <em>SLCO1B1</em> in vitro<sup><a href="#B43" rid="B43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243025">43</a>,<a href="#B48" rid="B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243057">48</a></sup> and in vivo (eg, statins).<sup><a href="#B49" rid="B49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243014">49</a></sup> The <em>SLCO1B1</em> T521C SNP was in high LD (<em>r</em><sup>2</sup> = 0.84) with the SNPs interrogated on the genome-wide arrays we used, and our independent genotyping confirmed an association of lower methotrexate clearance (higher systemic exposure) with the C allele. This is consistent with prior studies that demonstrate greater plasma exposure to multiple <em>SLCO1B1</em> substrates in those carrying the 521C allele than those homozygous for the 521T allele.<sup><a href="#B49" rid="B49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243032">49</a>–<a href="#B51" rid="B51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243016">51</a></sup> Nonetheless, most of the <em>SLCO1B1</em> SNPs that were associated with clearance (<a href="/pmc/articles/PMC2793040/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>) were noncoding SNPs, not in LD with T521C, and in a multivariate model, SNPs other than T521C maintained an association with methotrexate clearance (Data Supplement Table 10). The fact that these SNPs resided throughout the gene suggest multiple mechanisms by which variations affect the function of <em>SLCO1B1</em>, perhaps by effects on transcription and post-transcriptional processing (eg, pre-mRNA splicing and mRNA translation). Moreover, noncoding SNPs may be in linkage with rare, nontyped coding SNPs. Thus it appears that the function of <em>SLCO1B1</em> may be affected by several different polymorphisms.</p><p id="__p43">SNPs in <em>SLCO1B1</em> were associated not only with methotrexate clearance but also with GI toxicity (<a href="/pmc/articles/PMC2793040/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig 3</span></a>) in Total XIIIB. Only 5% of patients in Total XV had toxicity, and this may in part be attributed to targeting of methotrexate to achieve a specific plasma concentration. The alleles that were associated with lower plasma exposure were always associated with increased GI toxicity. This finding is consistent with lower blood concentrations but higher GI tract or enterocyte concentrations of methotrexate being associated with GI toxicity. The fact that <em>SLCO1B1</em> polymorphisms were not associated with the other common toxicity,<sup><a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243055">26</a></sup> infection, is consistent with GI concentrations being a determinant of methotrexate GI toxicity<sup><a href="#B52" rid="B52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243050">52</a>,<a href="#B53" rid="B53" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243049">53</a></sup> and being of relatively minor importance for infectious toxicity. Because 6-mercaptopurine was given during consolidation, toxicity (particularly infection) may have been partly due to 6-mercaptopurine. However, GI toxicity is more closely linked to methotrexate<sup><a href="#B53" rid="B53" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243011">53</a></sup> than to thiopurines.<sup><a href="#B54" rid="B54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243015">54</a>,<a href="#B55" rid="B55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243039">55</a></sup></p><p id="__p44"><em>SLCO1B1</em> genotypes were associated with methotrexate clearance across three different treatment regimens (<a href="/pmc/articles/PMC2793040/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig 3</span></a>) and were significant after adjusting for regimen differences and for sex, race, renal function, and age (<a href="/pmc/articles/PMC2793040/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a> and Data Supplement Table 6). Moreover, clearance was measured on multiple occasions, and thus the average value of clearance is a composite that already accounts for intrapatient variability that may have been due to nongenetic causes. Accounting for each course independently in a mixed effects model, and accounting for variation in serum creatinine,<sup><a href="#B56" rid="B56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243028">56</a></sup> polymorphisms in <em>SLCO1B1</em> remained significant predictors of interpatient variability in clearance. The fact that serum creatinine explained a small fraction (2.4%) of the interpatient variability in methotrexate clearance may be because serum creatinine was monitored before administration of the drug, and renal dysfunction was a contraindication to high-dose methotrexate. The proportion (9.3%) of interpatient variability in drug clearance attributable to germline variation in a single gene is on par with or greater than the variability accounted for by a single gene for other complex phenotypes.<sup><a href="#B57" rid="B57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243021">57</a></sup></p><p id="__p45">Identifying patients at risk of low methotrexate clearance could be useful for monitoring and supportive care during high-dose methotrexate, particularly in settings in which rapid turnaround of plasma levels is not available. Moreover, identifying that <em>SLCO1B1</em> accounts for a substantial degree of interpatient variability in clearance highlights that drug interactions are likely to occur if a potent <em>SLCO1B1</em> substrate is given with methotrexate.</p><p id="__p46">Methotrexate is metabolized to a 7-OH methotrexate metabolite.<sup><a href="#B58" rid="B58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243036">58</a></sup> This metabolite could interact with <em>SLCO1B1</em>. Other genetic variations may influence methotrexate clearance, such as in <em>SLCO1A2</em> (Data Supplement Tables 3-5).<sup><a href="#B59" rid="B59" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_187243012">59</a></sup> Moreover, there may be important insertion/deletion or germline copy number variations that were not adequately interrogated on the array we used.</p><p id="__p47" class="p p-last">Using a whole-genome approach, we identified a plausible candidate gene, <em>SLCO1B1</em>, that is associated with methotrexate pharmacokinetics and pharmacodynamics. This illustrates the proof of principle that genome-wide tools can lead to the discovery of important pharmacogenetic links between inherited genomic variation and drug response in humans.</p></div><div id="__sec13" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec13title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="PMC_1">
            
               <!--caption a9--><strong>[Data Supplement]</strong>
            
            <div class="sup-box half_rhythm" id="idm140305980321680"><a href="/pmc/articles/PMC2793040/bin/JCO.2008.20.4156_index.html" data-ga-action="click_feat_suppl">Click here to view.</a></div>
            
         </div></div><div id="idm140305981390112" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140305981390112title">Acknowledgment</h2><div class="sec"><p id="__p58">We thank our protocol coinvestigators, clinical and research staff, particularly Pamela McGill, Natalie Lowery, Sean Freeman, Nancy Kornegay, and Jennifer Pauley, PharmD, as well as patients and families for their participation. We thank the staff from the St Jude Hartwell Center for Bioinformatics and Biotechnology.</p></div></div><div id="idm140305980317472" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140305980317472title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140305980317344"></p><p id="__p48" class="p p-first-last">Supported by National Cancer Institute Grants No. CA 51001, CA 078224, and CA 21765; National Institutes of Health/National Institute of General Medical Sciences Pharmacogenetics Research Network and Database Grants No. U01 GM61393, U01 HL65899, and U01GM61374; a Center of Excellence grant from the State of Tennessee; and by the American Lebanese Syrian Associated Charities.</p><p></p><p class="fn sec" id="idm140305972207504"> </p><p id="__p49" class="p p-first-last">Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.</p><p></p></div></div><div id="__sec14" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec14title">AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST</h2><!--/article/back/sec/--><p id="__p50" class="p p-first-last">The author(s) indicated no potential conflicts of interest.</p></div><div id="__sec15" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec15title">AUTHOR CONTRIBUTIONS</h2><!--/article/back/sec/--><p id="__p51" class="p p-first"><strong>Conception and design:</strong> Mary V. Relling</p><p id="__p52"><strong>Financial support:</strong> Mary V. Relling, William E. Evans</p><p id="__p53"><strong>Administrative support:</strong> Ching-Hon Pui, William E. Evans, Mary V. Relling</p><p id="__p54"><strong>Collection and assembly of data:</strong> Lisa R. Treviño, Noriko Shimasaki</p><p id="__p55"><strong>Data analysis and interpretation:</strong> Lisa R. Treviño, Noriko Shimasaki, Wenjian Yang, John C. Panetta, Cheng Cheng, Deqing Pei, Diana Chan, Alex Sparreboom, Kathleen M. Giacomini, William E. Evans, Mary V. Relling</p><p id="__p56"><strong>Manuscript writing:</strong> Lisa R. Treviño, Mary V. Relling</p><p id="__p57" class="p p-last"><strong>Final approval of manuscript:</strong> Lisa R. Treviño, Noriko Shimasaki, Wenjian Yang, John C. Panetta, Cheng Cheng, Deqing Pei, Diana Chan, Alex Sparreboom, Kathleen M. Giacomini, Ching-Hon Pui, William E. Evans, Mary V. Relling</p></div><div id="idm140305980053824" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140305980053824title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="element-citation">Gudmundsson J, Sulem P, Steinthorsdottir V, et al.  Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:977–983.</span> [<a href="/pubmed/17603485" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Two+variants+on+chromosome+17+confer+prostate+cancer+risk,+and+the+one+in+TCF2+protects+against+type+2+diabetes&amp;author=J+Gudmundsson&amp;author=P+Sulem&amp;author=V+Steinthorsdottir&amp;volume=39&amp;publication_year=2007&amp;pages=977-983&amp;pmid=17603485&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="element-citation">Hakonarson H, Grant SF, Bradfield JP, et al.  A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">448</span>:591–594.</span> [<a href="/pubmed/17632545" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A+genome-wide+association+study+identifies+KIAA0350+as+a+type+1+diabetes+gene&amp;author=H+Hakonarson&amp;author=SF+Grant&amp;author=JP+Bradfield&amp;volume=448&amp;publication_year=2007&amp;pages=591-594&amp;pmid=17632545&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="element-citation">McPherson R, Pertsemlidis A, Kavaslar N, et al.  A common allele on chromosome 9 associated with coronary heart disease. <span><span class="ref-journal">Science. </span>2007;<span class="ref-vol">316</span>:1488–1491.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2711874/">PMC free article</a>]</span> [<a href="/pubmed/17478681" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=A+common+allele+on+chromosome+9+associated+with+coronary+heart+disease&amp;author=R+McPherson&amp;author=A+Pertsemlidis&amp;author=N+Kavaslar&amp;volume=316&amp;publication_year=2007&amp;pages=1488-1491&amp;pmid=17478681&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="element-citation">Samani NJ, Erdmann J, Hall AS, et al.  Genomewide association analysis of coronary artery disease. <span><span class="ref-journal">N Engl J Med. </span>2007;<span class="ref-vol">357</span>:443–453.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2719290/">PMC free article</a>]</span> [<a href="/pubmed/17634449" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Genomewide+association+analysis+of+coronary+artery+disease&amp;author=NJ+Samani&amp;author=J+Erdmann&amp;author=AS+Hall&amp;volume=357&amp;publication_year=2007&amp;pages=443-453&amp;pmid=17634449&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="element-citation">Yeager M, Orr N, Hayes RB, et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:645–649.</span> [<a href="/pubmed/17401363" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Genome-wide+association+study+of+prostate+cancer+identifies+a+second+risk+locus+at+8q24&amp;author=M+Yeager&amp;author=N+Orr&amp;author=RB+Hayes&amp;volume=39&amp;publication_year=2007&amp;pages=645-649&amp;pmid=17401363&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="element-citation">Goldstein DB. Pharmacogenetics in the laboratory and the clinic. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:553–556.</span> [<a href="/pubmed/12571264" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Pharmacogenetics+in+the+laboratory+and+the+clinic&amp;author=DB+Goldstein&amp;volume=348&amp;publication_year=2003&amp;pages=553-556&amp;pmid=12571264&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="element-citation">Evans WE, McLeod HL. Pharmacogenomics–drug disposition, drug targets, and side effects. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:538–549.</span> [<a href="/pubmed/12571262" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Pharmacogenomics–drug+disposition,+drug+targets,+and+side+effects&amp;author=WE+Evans&amp;author=HL+McLeod&amp;volume=348&amp;publication_year=2003&amp;pages=538-549&amp;pmid=12571262&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="element-citation">Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. <span><span class="ref-journal">Nature. </span>2004;<span class="ref-vol">429</span>:464–468.</span> [<a href="/pubmed/15164072" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Moving+towards+individualized+medicine+with+pharmacogenomics&amp;author=WE+Evans&amp;author=MV+Relling&amp;volume=429&amp;publication_year=2004&amp;pages=464-468&amp;pmid=15164072&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="element-citation">Meyer UA. Pharmacogenetics and adverse drug reactions. <span><span class="ref-journal">Lancet. </span>2000;<span class="ref-vol">356</span>:1667–1671.</span> [<a href="/pubmed/11089838" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Pharmacogenetics+and+adverse+drug+reactions&amp;author=UA+Meyer&amp;volume=356&amp;publication_year=2000&amp;pages=1667-1671&amp;pmid=11089838&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="element-citation">Roden DM, Altman RB, Benowitz NL, et al.  Pharmacogenomics: Challenges and opportunities. <span><span class="ref-journal">Ann Intern Med. </span>2006;<span class="ref-vol">145</span>:749–757.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5006954/">PMC free article</a>]</span> [<a href="/pubmed/17116919" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Intern+Med&amp;title=Pharmacogenomics:+Challenges+and+opportunities&amp;author=DM+Roden&amp;author=RB+Altman&amp;author=NL+Benowitz&amp;volume=145&amp;publication_year=2006&amp;pages=749-757&amp;pmid=17116919&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="element-citation">Jolivet J, Cowan KH, Curt GA, et al.  The pharmacology and clinical use of methotrexate. <span><span class="ref-journal">N Engl J Med. </span>1983;<span class="ref-vol">309</span>:1094–1104.</span> [<a href="/pubmed/6353235" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=The+pharmacology+and+clinical+use+of+methotrexate&amp;author=J+Jolivet&amp;author=KH+Cowan&amp;author=GA+Curt&amp;volume=309&amp;publication_year=1983&amp;pages=1094-1104&amp;pmid=6353235&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="element-citation">Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. <span><span class="ref-journal">N Engl J Med. </span>2004;<span class="ref-vol">350</span>:1535–1548.</span> [<a href="/pubmed/15071128" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Acute+lymphoblastic+leukemia&amp;author=CH+Pui&amp;author=MV+Relling&amp;author=JR+Downing&amp;volume=350&amp;publication_year=2004&amp;pages=1535-1548&amp;pmid=15071128&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="element-citation">Olsen NJ, Stein CM. New drugs for rheumatoid arthritis. <span><span class="ref-journal">N Engl J Med. </span>2004;<span class="ref-vol">350</span>:2167–2179.</span> [<a href="/pubmed/15152062" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=New+drugs+for+rheumatoid+arthritis&amp;author=NJ+Olsen&amp;author=CM+Stein&amp;volume=350&amp;publication_year=2004&amp;pages=2167-2179&amp;pmid=15152062&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="element-citation">Wessels JA, van der Kooij SM, le Cessie S, et al.  A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis. <span><span class="ref-journal">Arthritis Rheum. </span>2007;<span class="ref-vol">56</span>:1765–1775.</span> [<a href="/pubmed/17530705" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;title=A+clinical+pharmacogenetic+model+to+predict+the+efficacy+of+methotrexate+monotherapy+in+recent-onset+rheumatoid+arthritis&amp;author=JA+Wessels&amp;author=SM+van+der+Kooij&amp;author=S+le+Cessie&amp;volume=56&amp;publication_year=2007&amp;pages=1765-1775&amp;pmid=17530705&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="element-citation">Niemeyer CM, Gelber RD, Tarbell NJ, et al.  Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (protocol 81-01 update) <span><span class="ref-journal">Blood. </span>1991;<span class="ref-vol">78</span>:2514–2519.</span> [<a href="/pubmed/1824248" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Low-dose+versus+high-dose+methotrexate+during+remission+induction+in+childhood+acute+lymphoblastic+leukemia+(protocol+81-01+update)&amp;author=CM+Niemeyer&amp;author=RD+Gelber&amp;author=NJ+Tarbell&amp;volume=78&amp;publication_year=1991&amp;pages=2514-2519&amp;pmid=1824248&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="element-citation">Evans WE, Crom WR, Stewart CF, et al.  Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia. <span><span class="ref-journal">Lancet. </span>1984;<span class="ref-vol">1</span>:359–362.</span> [<a href="/pubmed/6141424" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Methotrexate+systemic+clearance+influences+probability+of+relapse+in+children+with+standard-risk+acute+lymphocytic+leukaemia&amp;author=WE+Evans&amp;author=WR+Crom&amp;author=CF+Stewart&amp;volume=1&amp;publication_year=1984&amp;pages=359-362&amp;pmid=6141424&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="element-citation">Evans WE, Crom WR, Abromowitch M, et al.  Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect. <span><span class="ref-journal">N Engl J Med. </span>1986;<span class="ref-vol">314</span>:471–477.</span> [<a href="/pubmed/3456079" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Clinical+pharmacodynamics+of+high-dose+methotrexate+in+acute+lymphocytic+leukemia.+Identification+of+a+relation+between+concentration+and+effect&amp;author=WE+Evans&amp;author=WR+Crom&amp;author=M+Abromowitch&amp;volume=314&amp;publication_year=1986&amp;pages=471-477&amp;pmid=3456079&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="element-citation">Camitta B, Leventhal B, Lauer S, et al.  Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: A Pediatric Oncology Group study. <span><span class="ref-journal">J Clin Oncol. </span>1989;<span class="ref-vol">7</span>:1539–1544.</span> [<a href="/pubmed/2778483" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Intermediate-dose+intravenous+methotrexate+and+mercaptopurine+therapy+for+non-T,+non-B+acute+lymphocytic+leukemia+of+childhood:+A+Pediatric+Oncology+Group+study&amp;author=B+Camitta&amp;author=B+Leventhal&amp;author=S+Lauer&amp;volume=7&amp;publication_year=1989&amp;pages=1539-1544&amp;pmid=2778483&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="element-citation">Evans WE, Relling MV, Rodman JH, et al.  Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. <span><span class="ref-journal">N Engl J Med. </span>1998;<span class="ref-vol">338</span>:499–505.</span> [<a href="/pubmed/9468466" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Conventional+compared+with+individualized+chemotherapy+for+childhood+acute+lymphoblastic+leukemia&amp;author=WE+Evans&amp;author=MV+Relling&amp;author=JH+Rodman&amp;volume=338&amp;publication_year=1998&amp;pages=499-505&amp;pmid=9468466&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="element-citation">Abelson HT, Fosburg MT, Beardsley GP, et al.  Methotrexate-induced renal impairment: Clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. <span><span class="ref-journal">J Clin Oncol. </span>1983;<span class="ref-vol">1</span>:208–216.</span> [<a href="/pubmed/6607976" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Methotrexate-induced+renal+impairment:+Clinical+studies+and+rescue+from+systemic+toxicity+with+high-dose+leucovorin+and+thymidine&amp;author=HT+Abelson&amp;author=MT+Fosburg&amp;author=GP+Beardsley&amp;volume=1&amp;publication_year=1983&amp;pages=208-216&amp;pmid=6607976&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="element-citation">Jaffe N, Gorlick R. High-dose methotrexate in osteosarcoma: Let the questions surcease–time for final acceptance. <span><span class="ref-journal">J Clin Oncol. </span>2008;<span class="ref-vol">26</span>:4365–4366.</span> [<a href="/pubmed/18802144" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=High-dose+methotrexate+in+osteosarcoma:+Let+the+questions+surcease–time+for+final+acceptance&amp;author=N+Jaffe&amp;author=R+Gorlick&amp;volume=26&amp;publication_year=2008&amp;pages=4365-4366&amp;pmid=18802144&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="element-citation">Relling MV, Fairclough D, Ayers D, et al.  Patient characteristics associated with high-risk methotrexate concentrations and toxicity. <span><span class="ref-journal">J Clin Oncol. </span>1994;<span class="ref-vol">12</span>:1667–1672.</span> [<a href="/pubmed/8040679" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Patient+characteristics+associated+with+high-risk+methotrexate+concentrations+and+toxicity&amp;author=MV+Relling&amp;author=D+Fairclough&amp;author=D+Ayers&amp;volume=12&amp;publication_year=1994&amp;pages=1667-1672&amp;pmid=8040679&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="element-citation">Woessmann W, Seidemann K, Mann G, et al.  The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: A report of the BFM Group Study NHL-BFM95. <span><span class="ref-journal">Blood. </span>2005;<span class="ref-vol">105</span>:948–958.</span> [<a href="/pubmed/15486066" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=The+impact+of+the+methotrexate+administration+schedule+and+dose+in+the+treatment+of+children+and+adolescents+with+B-cell+neoplasms:+A+report+of+the+BFM+Group+Study+NHL-BFM95&amp;author=W+Woessmann&amp;author=K+Seidemann&amp;author=G+Mann&amp;volume=105&amp;publication_year=2005&amp;pages=948-958&amp;pmid=15486066&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="element-citation">Laverdière C, Chiasson S, Costea I, et al.  Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia. <span><span class="ref-journal">Blood. </span>2002;<span class="ref-vol">100</span>:3832–3834.</span> [<a href="/pubmed/12411325" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Polymorphism+G80A+in+the+reduced+folate+carrier+gene+and+its+relationship+to+methotrexate+plasma+levels+and+outcome+of+childhood+acute+lymphoblastic+leukemia&amp;author=C+Laverdière&amp;author=S+Chiasson&amp;author=I+Costea&amp;volume=100&amp;publication_year=2002&amp;pages=3832-3834&amp;pmid=12411325&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="element-citation">de Jonge R, Hooijberg JH, van Zelst BD, et al.  Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia. <span><span class="ref-journal">Blood. </span>2005;<span class="ref-vol">106</span>:717–720.</span> [<a href="/pubmed/15797993" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Effect+of+polymorphisms+in+folate-related+genes+on+in+vitro+methotrexate+sensitivity+in+pediatric+acute+lymphoblastic+leukemia&amp;author=R+de+Jonge&amp;author=JH+Hooijberg&amp;author=BD+van+Zelst&amp;volume=106&amp;publication_year=2005&amp;pages=717-720&amp;pmid=15797993&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="element-citation">Kishi S, Cheng C, French D, et al.  Ancestry and pharmacogenetics of antileukemic drug toxicity. <span><span class="ref-journal">Blood. </span>2007;<span class="ref-vol">109</span>:4151–4157.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1885506/">PMC free article</a>]</span> [<a href="/pubmed/17264302" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Ancestry+and+pharmacogenetics+of+antileukemic+drug+toxicity&amp;author=S+Kishi&amp;author=C+Cheng&amp;author=D+French&amp;volume=109&amp;publication_year=2007&amp;pages=4151-4157&amp;pmid=17264302&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="element-citation">Pui CH, Sandlund JT, Pei D, et al.  Improved outcome for children with acute lymphoblastic leukemia: Results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. <span><span class="ref-journal">Blood. </span>2004;<span class="ref-vol">104</span>:2690–2696.</span> [<a href="/pubmed/15251979" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Improved+outcome+for+children+with+acute+lymphoblastic+leukemia:+Results+of+Total+Therapy+Study+XIIIB+at+St+Jude+Children's+Research+Hospital&amp;author=CH+Pui&amp;author=JT+Sandlund&amp;author=D+Pei&amp;volume=104&amp;publication_year=2004&amp;pages=2690-2696&amp;pmid=15251979&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="element-citation">Pui CH, Campana D, Pei D, et al.  Treating childhood acute lymphoblastic leukemia without cranial irradiation. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">360</span>:2730–2741.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2754320/">PMC free article</a>]</span> [<a href="/pubmed/19553647" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Treating+childhood+acute+lymphoblastic+leukemia+without+cranial+irradiation&amp;author=CH+Pui&amp;author=D+Campana&amp;author=D+Pei&amp;volume=360&amp;publication_year=2009&amp;pages=2730-2741&amp;pmid=19553647&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="element-citation">Kishi S, Griener J, Cheng C, et al.  Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. <span><span class="ref-journal">J Clin Oncol. </span>2003;<span class="ref-vol">21</span>:3084–3091.</span> [<a href="/pubmed/12915598" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Homocysteine,+pharmacogenetics,+and+neurotoxicity+in+children+with+leukemia&amp;author=S+Kishi&amp;author=J+Griener&amp;author=C+Cheng&amp;volume=21&amp;publication_year=2003&amp;pages=3084-3091&amp;pmid=12915598&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="element-citation">Pauley JL, Panetta JC, Schmidt J, et al.  Late-onset delayed excretion of methotrexate. <span><span class="ref-journal">Cancer Chemother Pharmacol. </span>2004;<span class="ref-vol">54</span>:146–152.</span> [<a href="/pubmed/15148625" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Chemother+Pharmacol&amp;title=Late-onset+delayed+excretion+of+methotrexate&amp;author=JL+Pauley&amp;author=JC+Panetta&amp;author=J+Schmidt&amp;volume=54&amp;publication_year=2004&amp;pages=146-152&amp;pmid=15148625&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="element-citation">Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: Applications to inferring missing genotypes and haplotypic phase. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">78</span>:629–644.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1424677/">PMC free article</a>]</span> [<a href="/pubmed/16532393" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=A+fast+and+flexible+statistical+model+for+large-scale+population+genotype+data:+Applications+to+inferring+missing+genotypes+and+haplotypic+phase&amp;author=P+Scheet&amp;author=M+Stephens&amp;volume=78&amp;publication_year=2006&amp;pages=629-644&amp;pmid=16532393&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="element-citation">Price AL, Patterson NJ, Plenge RM, et al.  Principal components analysis corrects for stratification in genome-wide association studies. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:904–909.</span> [<a href="/pubmed/16862161" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Principal+components+analysis+corrects+for+stratification+in+genome-wide+association+studies&amp;author=AL+Price&amp;author=NJ+Patterson&amp;author=RM+Plenge&amp;volume=38&amp;publication_year=2006&amp;pages=904-909&amp;pmid=16862161&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="element-citation">Pinheiro JC, Bates DM. <span><span class="ref-journal">Mixed-Effects Models in S and S-Plus. </span>2000</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mixed-Effects+Models+in+S+and+S-Plus&amp;author=JC+Pinheiro&amp;author=DM+Bates&amp;publication_year=2000&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="element-citation">Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. <span><span class="ref-journal">Annals Stat. </span>1988;<span class="ref-vol">16</span>:1141–1154.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annals+Stat&amp;title=A+class+of+K-sample+tests+for+comparing+the+cumulative+incidence+of+a+competing+risk&amp;author=RJ+Gray&amp;volume=16&amp;publication_year=1988&amp;pages=1141-1154&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="element-citation">Krajinovic M, Moghrabi A. Pharmacogenetics of methotrexate. <span><span class="ref-journal">Pharmacogenomics. </span>2004;<span class="ref-vol">5</span>:819–834.</span> [<a href="/pubmed/15469405" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics&amp;title=Pharmacogenetics+of+methotrexate&amp;author=M+Krajinovic&amp;author=A+Moghrabi&amp;volume=5&amp;publication_year=2004&amp;pages=819-834&amp;pmid=15469405&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="element-citation">Ansari M, Krajinovic M. Pharmacogenomics in cancer treatment defining genetic bases for inter-individual differences in responses to chemotherapy. <span><span class="ref-journal">Curr Opin Pediatr. </span>2007;<span class="ref-vol">19</span>:15–22.</span> [<a href="/pubmed/17224657" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Pediatr&amp;title=Pharmacogenomics+in+cancer+treatment+defining+genetic+bases+for+inter-individual+differences+in+responses+to+chemotherapy&amp;author=M+Ansari&amp;author=M+Krajinovic&amp;volume=19&amp;publication_year=2007&amp;pages=15-22&amp;pmid=17224657&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="element-citation">Cheok MH, Evans WE. Acute lymphoblastic leukaemia: A model for the pharmacogenomics of cancer therapy 2. <span><span class="ref-journal">Nat Rev Cancer. </span>2006;<span class="ref-vol">6</span>:117–129.</span> [<a href="/pubmed/16491071" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;title=Acute+lymphoblastic+leukaemia:+A+model+for+the+pharmacogenomics+of+cancer+therapy+2&amp;author=MH+Cheok&amp;author=WE+Evans&amp;volume=6&amp;publication_year=2006&amp;pages=117-129&amp;pmid=16491071&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="element-citation">Kager L, Evans WE. Pharmacogenomics of acute lymphoblastic leukemia. <span><span class="ref-journal">Curr Opin Hematol. </span>2006;<span class="ref-vol">13</span>:260–265.</span> [<a href="/pubmed/16755223" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Hematol&amp;title=Pharmacogenomics+of+acute+lymphoblastic+leukemia&amp;author=L+Kager&amp;author=WE+Evans&amp;volume=13&amp;publication_year=2006&amp;pages=260-265&amp;pmid=16755223&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39">39. <span class="element-citation">Abe T, Kakyo M, Tokui T, et al.  Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:17159–17163.</span> [<a href="/pubmed/10358072" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Identification+of+a+novel+gene+family+encoding+human+liver-specific+organic+anion+transporter+LST-1&amp;author=T+Abe&amp;author=M+Kakyo&amp;author=T+Tokui&amp;volume=274&amp;publication_year=1999&amp;pages=17159-17163&amp;pmid=10358072&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40">40. <span class="element-citation">Marzolini C, Tirona RG, Gervasini G, et al.  A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression 10. <span><span class="ref-journal">Mol Endocrinol. </span>2007;<span class="ref-vol">21</span>:1769–1780.</span> [<a href="/pubmed/17519356" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Endocrinol&amp;title=A+common+polymorphism+in+the+bile+acid+receptor+farnesoid+X+receptor+is+associated+with+decreased+hepatic+target+gene+expression+10&amp;author=C+Marzolini&amp;author=RG+Tirona&amp;author=G+Gervasini&amp;volume=21&amp;publication_year=2007&amp;pages=1769-1780&amp;pmid=17519356&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41">41. <span class="element-citation">Glaeser H, Bailey DG, Dresser GK, et al.  Intestinal drug transporter expression and the impact of grapefruit juice in humans. <span><span class="ref-journal">Clin Pharmacol Ther. </span>2007;<span class="ref-vol">81</span>:362–370.</span> [<a href="/pubmed/17215845" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;title=Intestinal+drug+transporter+expression+and+the+impact+of+grapefruit+juice+in+humans&amp;author=H+Glaeser&amp;author=DG+Bailey&amp;author=GK+Dresser&amp;volume=81&amp;publication_year=2007&amp;pages=362-370&amp;pmid=17215845&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B42">42. <span class="element-citation">Abe T, Unno M, Onogawa T, et al.  LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. <span><span class="ref-journal">Gastroenterology. </span>2001;<span class="ref-vol">120</span>:1689–1699.</span> [<a href="/pubmed/11375950" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=LST-2,+a+human+liver-specific+organic+anion+transporter,+determines+methotrexate+sensitivity+in+gastrointestinal+cancers&amp;author=T+Abe&amp;author=M+Unno&amp;author=T+Onogawa&amp;volume=120&amp;publication_year=2001&amp;pages=1689-1699&amp;pmid=11375950&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B43">43. <span class="element-citation">Tirona RG, Leake BF, Merino G, et al.  Polymorphisms in OATP-C: Identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. <span><span class="ref-journal">J Biol Chem. </span>2001;<span class="ref-vol">276</span>:35669–35675.</span> [<a href="/pubmed/11477075" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Polymorphisms+in+OATP-C:+Identification+of+multiple+allelic+variants+associated+with+altered+transport+activity+among+European-+and+African-Americans&amp;author=RG+Tirona&amp;author=BF+Leake&amp;author=G+Merino&amp;volume=276&amp;publication_year=2001&amp;pages=35669-35675&amp;pmid=11477075&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B44">44. <span class="element-citation">Niemi M, Schaeffeler E, Lang T, et al.  High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1) <span><span class="ref-journal">Pharmacogenetics. </span>2004;<span class="ref-vol">14</span>:429–440.</span> [<a href="/pubmed/15226675" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenetics&amp;title=High+plasma+pravastatin+concentrations+are+associated+with+single+nucleotide+polymorphisms+and+haplotypes+of+organic+anion+transporting+polypeptide-C+(OATP-C,+SLCO1B1)&amp;author=M+Niemi&amp;author=E+Schaeffeler&amp;author=T+Lang&amp;volume=14&amp;publication_year=2004&amp;pages=429-440&amp;pmid=15226675&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B45">45. <span class="element-citation">Pasanen MK, Neuvonen M, Neuvonen PJ, et al.  SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid. <span><span class="ref-journal">Pharmacogenet Genomics. </span>2006;<span class="ref-vol">16</span>:873–879.</span> [<a href="/pubmed/17108811" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenet+Genomics&amp;title=SLCO1B1+polymorphism+markedly+affects+the+pharmacokinetics+of+simvastatin+acid&amp;author=MK+Pasanen&amp;author=M+Neuvonen&amp;author=PJ+Neuvonen&amp;volume=16&amp;publication_year=2006&amp;pages=873-879&amp;pmid=17108811&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B46">46. <span class="element-citation">Liu L, Cui Y, Chung AY, et al.  Vectorial transport of enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in rat and human livers. <span><span class="ref-journal">J Pharmacol Exp Ther. </span>2006;<span class="ref-vol">318</span>:395–402.</span> [<a href="/pubmed/16627748" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;title=Vectorial+transport+of+enalapril+by+Oatp1a1/Mrp2+and+OATP1B1+and+OATP1B3/MRP2+in+rat+and+human+livers&amp;author=L+Liu&amp;author=Y+Cui&amp;author=AY+Chung&amp;volume=318&amp;publication_year=2006&amp;pages=395-402&amp;pmid=16627748&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B47">47. <span class="element-citation">Nozawa T, Minami H, Sugiura S, et al.  Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: In vitro evidence and effect of single nucleotide polymorphisms. <span><span class="ref-journal">Drug Metab Dispos. </span>2005;<span class="ref-vol">33</span>:434–439.</span> [<a href="/pubmed/15608127" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Metab+Dispos&amp;title=Role+of+organic+anion+transporter+OATP1B1+(OATP-C)+in+hepatic+uptake+of+irinotecan+and+its+active+metabolite,+7-ethyl-10-hydroxycamptothecin:+In+vitro+evidence+and+effect+of+single+nucleotide+polymorphisms&amp;author=T+Nozawa&amp;author=H+Minami&amp;author=S+Sugiura&amp;volume=33&amp;publication_year=2005&amp;pages=434-439&amp;pmid=15608127&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B48">48. <span class="element-citation">Kameyama Y, Yamashita K, Kobayashi K, et al.  Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+ C1007G, by using transient expression systems of HeLa and HEK293 cells. <span><span class="ref-journal">Pharmacogenet Genomics. </span>2005;<span class="ref-vol">15</span>:513–522.</span> [<a href="/pubmed/15970799" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenet+Genomics&amp;title=Functional+characterization+of+SLCO1B1+(OATP-C)+variants,+SLCO1B1*5,+SLCO1B1*15+and+SLCO1B1*15++C1007G,+by+using+transient+expression+systems+of+HeLa+and+HEK293+cells&amp;author=Y+Kameyama&amp;author=K+Yamashita&amp;author=K+Kobayashi&amp;volume=15&amp;publication_year=2005&amp;pages=513-522&amp;pmid=15970799&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B49">49. <span class="element-citation">Pasanen MK, Fredrikson H, Neuvonen PJ, et al.  Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin. <span><span class="ref-journal">Clin Pharmacol Ther. </span>2007;<span class="ref-vol">82</span>:726–733.</span> [<a href="/pubmed/17473846" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;title=Different+effects+of+SLCO1B1+polymorphism+on+the+pharmacokinetics+of+atorvastatin+and+rosuvastatin&amp;author=MK+Pasanen&amp;author=H+Fredrikson&amp;author=PJ+Neuvonen&amp;volume=82&amp;publication_year=2007&amp;pages=726-733&amp;pmid=17473846&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B50">50. <span class="element-citation">Ho RH, Choi L, Lee W, et al.  Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants. <span><span class="ref-journal">Pharmacogenet Genomics. </span>2007;<span class="ref-vol">17</span>:647–656.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4063287/">PMC free article</a>]</span> [<a href="/pubmed/17622941" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenet+Genomics&amp;title=Effect+of+drug+transporter+genotypes+on+pravastatin+disposition+in+European-+and+African-American+participants&amp;author=RH+Ho&amp;author=L+Choi&amp;author=W+Lee&amp;volume=17&amp;publication_year=2007&amp;pages=647-656&amp;pmid=17622941&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B51">51. <span class="element-citation">Niemi M. Role of OATP transporters in the disposition of drugs. <span><span class="ref-journal">Pharmacogenomics. </span>2007;<span class="ref-vol">8</span>:787–802.</span> [<a href="/pubmed/18240907" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics&amp;title=Role+of+OATP+transporters+in+the+disposition+of+drugs&amp;author=M+Niemi&amp;volume=8&amp;publication_year=2007&amp;pages=787-802&amp;pmid=18240907&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B52">52. <span class="element-citation">Egan LJ, Sandborn WJ, Mays DC, et al.  Systemic and intestinal pharmacokinetics of methotrexate in patients with inflammatory bowel disease. <span><span class="ref-journal">Clin Pharmacol Ther. </span>1999;<span class="ref-vol">65</span>:29–39.</span> [<a href="/pubmed/9951428" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;title=Systemic+and+intestinal+pharmacokinetics+of+methotrexate+in+patients+with+inflammatory+bowel+disease&amp;author=LJ+Egan&amp;author=WJ+Sandborn&amp;author=DC+Mays&amp;volume=65&amp;publication_year=1999&amp;pages=29-39&amp;pmid=9951428&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B53">53. <span class="element-citation">Evans WE, Tsiatis A, Crom WR, et al.  Pharmacokinetics of sustained serum methotrexate concentrations secondary to gastrointestinal obstruction. <span><span class="ref-journal">J Pharm Sci. </span>1981;<span class="ref-vol">70</span>:1194–1198.</span> [<a href="/pubmed/7299661" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Sci&amp;title=Pharmacokinetics+of+sustained+serum+methotrexate+concentrations+secondary+to+gastrointestinal+obstruction&amp;author=WE+Evans&amp;author=A+Tsiatis&amp;author=WR+Crom&amp;volume=70&amp;publication_year=1981&amp;pages=1194-1198&amp;pmid=7299661&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B54">54. <span class="element-citation">Connell WR, Kamm MA, Ritchie JK, et al.  Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. <span><span class="ref-journal">Gut. </span>1993;<span class="ref-vol">34</span>:1081–1085.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1374358/">PMC free article</a>]</span> [<a href="/pubmed/8174958" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Bone+marrow+toxicity+caused+by+azathioprine+in+inflammatory+bowel+disease:+27+years+of+experience&amp;author=WR+Connell&amp;author=MA+Kamm&amp;author=JK+Ritchie&amp;volume=34&amp;publication_year=1993&amp;pages=1081-1085&amp;pmid=8174958&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B55">55. <span class="element-citation">Present DH, Meltzer SJ, Krumholz MP, et al.  6-Mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity. <span><span class="ref-journal">Ann Intern Med. </span>1989;<span class="ref-vol">111</span>:641–649.</span> [<a href="/pubmed/2802419" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Intern+Med&amp;title=6-Mercaptopurine+in+the+management+of+inflammatory+bowel+disease:+Short-+and+long-term+toxicity&amp;author=DH+Present&amp;author=SJ+Meltzer&amp;author=MP+Krumholz&amp;volume=111&amp;publication_year=1989&amp;pages=641-649&amp;pmid=2802419&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B56">56. <span class="element-citation">Murry DJ, Synold TW, Pui CH, et al.  Renal function and methotrexate clearance in children with newly diagnosed leukemia. <span><span class="ref-journal">Pharmacotherapy. </span>1995;<span class="ref-vol">15</span>:144–149.</span> [<a href="/pubmed/7624260" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacotherapy&amp;title=Renal+function+and+methotrexate+clearance+in+children+with+newly+diagnosed+leukemia&amp;author=DJ+Murry&amp;author=TW+Synold&amp;author=CH+Pui&amp;volume=15&amp;publication_year=1995&amp;pages=144-149&amp;pmid=7624260&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B57">57. <span class="element-citation">Cohen JC, Boerwinkle E, Mosley TH, Jr, et al.  Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. <span><span class="ref-journal">N Engl J Med. </span>2006;<span class="ref-vol">354</span>:1264–1272.</span> [<a href="/pubmed/16554528" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Sequence+variations+in+PCSK9,+low+LDL,+and+protection+against+coronary+heart+disease&amp;author=JC+Cohen&amp;author=E+Boerwinkle&amp;author=TH+Mosley&amp;volume=354&amp;publication_year=2006&amp;pages=1264-1272&amp;pmid=16554528&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B58">58. <span class="element-citation">Fotoohi K, Jansen G, Assaraf YG, et al.  Disparate mechanisms of antifolate resistance provoked by methotrexate and its metabolite 7-hydroxymethotrexate in leukemia cells: Implications for efficacy of methotrexate therapy. <span><span class="ref-journal">Blood. </span>2004;<span class="ref-vol">104</span>:4194–4201.</span> [<a href="/pubmed/15308564" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Disparate+mechanisms+of+antifolate+resistance+provoked+by+methotrexate+and+its+metabolite+7-hydroxymethotrexate+in+leukemia+cells:+Implications+for+efficacy+of+methotrexate+therapy&amp;author=K+Fotoohi&amp;author=G+Jansen&amp;author=YG+Assaraf&amp;volume=104&amp;publication_year=2004&amp;pages=4194-4201&amp;pmid=15308564&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B59">59. <span class="element-citation">Badagnani I, Castro RA, Taylor TR, et al.  Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants. <span><span class="ref-journal">J Pharmacol Exp Ther. </span>2006;<span class="ref-vol">318</span>:521–529.</span> [<a href="/pubmed/16702441" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;title=Interaction+of+methotrexate+with+organic-anion+transporting+polypeptide+1A2+and+its+genetic+variants&amp;author=I+Badagnani&amp;author=RA+Castro&amp;author=TR+Taylor&amp;volume=318&amp;publication_year=2006&amp;pages=521-529&amp;pmid=16702441&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2793040&amp;issue-id=183517&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140305972509008title">Abstract</a></li><li><a href="#__sec5title">INTRODUCTION</a></li><li><a href="#__sec6title">PATIENTS AND METHODS</a></li><li><a href="#__sec11title">RESULTS</a></li><li><a href="#__sec12title">DISCUSSION</a></li><li><a href="#__sec13title">Supplementary Material</a></li><li><a href="#idm140305981390112title">Acknowledgment</a></li><li><a href="#idm140305980317472title">Footnotes</a></li><li><a href="#__sec14title">AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST</a></li><li><a href="#__sec15title">AUTHOR CONTRIBUTIONS</a></li><li><a href="#idm140305980053824title">REFERENCES</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">Journal of Clinical Oncology</span> are provided here courtesy of <strong>American Society of Clinical Oncology</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2793040/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2793040/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2793040/pdf/zlj5972.pdf">PDF (224K)</a></li> | <li><a href="#" data-citationid="PMC2793040" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2793040%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2793040%2F&amp;text=Germline%20Genetic%20Variation%20in%20an%20Organic%20Anion%20Transporter%20Polypeptide%20Associated%20With%20Methotrexate%20Pharmacokinetics%20and%20Clinical%20Effects" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2793040%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="19901119" data-aiid="2793040" data-aid="2793040" data-iid="183517" data-domainid="660" data-domain="jco" data-accid="PMC2793040" data-md5="94221cd7b8126711a095e7ae84642649"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T04:20:45-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal106&amp;ncbi_phid=CE8DC649DD5046010000000000BA0070&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2793040%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=jco&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2793040/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>